Don't Buy Neogen Without Checking Its Fundamentals!

Shares of Health Care sector company Neogen moved -0.4% today, and are now trading at a price of $23.09. The mid-cap stock's daily volume was 61,622 compared to its average volume of 1,616,095. The S&P 500 index returned a 0.0% performance.

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. The company is based in Lansing and has 2,640 full time employees. Its market capitalization is $5,061,258,752.

2 analysts are following Neogen and have set target prices ranging from $24.0 to $28.0 per share. On average, they have given the company a rating of buy. At today's prices, NEOG is trading -11.19% away from its average analyst target price of $26.0 per share.

Over the last year, NEOG's share price has increased by 10.0%, which represents a difference of 3.0% when compared to the S&P 500. The stock's 52 week high is $24.1 per share whereas its 52 week low is $10.49.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2022-07-27 68,038 -24,429 92,467 -14.22
2021-07-30 81,089 -26,712 107,801 -1.94
2020-07-30 85,878 -24,052 109,930 40.03
2019-07-30 63,842 -14,661 78,503 -12.85
2018-07-27 69,131 -20,946 90,077 20.34
2017-07-28 60,274 -14,578 74,852
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS